Coert J. Zuurbier
Amsterdam Neuroscience(NL)Amsterdam University of Applied Sciences(NL)University of Amsterdam(NL)
Publications by Year
Research Areas
Cardiac Ischemia and Reperfusion, Diabetes Treatment and Management, Mitochondrial Function and Pathology, Pancreatic function and diabetes, Cardiovascular Function and Risk Factors
Most-Cited Works
- → Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits(2016)634 cited
- → Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation(2017)586 cited
- → Cardiac metabolism as a driver and therapeutic target of myocardial infarction(2020)228 cited
- → Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells(2019)202 cited
- → Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients(2018)186 cited
- → Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells